Ycanth™ (cantharidin) – New drug approval
July 21, 2023 - Verrica Pharmaceuticals announced the FDA approval of Ycanth (cantharidin), for the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older.
Download PDF
